PharmaVoice 2026-02-12 Lilly’s $2.4B bet on off-the-shelf cell therapy is part of a wider Big Pharma shift
PharmaVoice 2026-02-11 A protein model designed for space could expand pharma’s definition of ‘druggability’
PharmaVoice 2026-02-03 Investors crave safer, market-ready biotech bets, widening the early-stage funding gap
PharmaVoice 2026-01-27 A potential gene therapy for heart failure is an approach decades in the making